K-V Pharmaceutical (KVPHQ) Says Bankruptcy Court Approves Hologic (HOLX) Settlement
K-V Pharmaceutical Company (OTC: KVPHQ) (NYSE: KV-A) today announced that the U. S. Bankruptcy Court for the Southern District of New York, the Honorable Judge Allan L. Gropper presiding, approved the Company's settlement agreement with Hologic, Inc. (Nasdaq: HOLX), and authorized the Company to enter into an $85 million debtor-in-possession financing to, among other things, fund the settlement.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Getty Realty discloses separation terms for departing accounting officer
- Genworth Financial CEO returns from leave of absence in September
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
BankruptcySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share